Qawasmi Feras, Segev Maria, Sobeh Tamer, Gorenstein Larisa, Abebe-Campino Gadi, Hoffmann Chen, Yalon Michal, Modan-Moses Dalit, Shrot Shai
Department of Diagnostic Imaging, Sheba Medical Center, Ramat-Gan, Israel.
Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
J Magn Reson Imaging. 2025 Jun;61(6):2516-2522. doi: 10.1002/jmri.29674. Epub 2024 Dec 9.
Pediatric brain cancer survivors often experience hypothalamic-pituitary dysfunction due to cranial irradiation and chemotherapy. While hormone deficiencies have been studied, the changes in pituitary size and shape on long-term MRI and their relationship to endocrine dysfunction remain under-explored.
To evaluate pituitary gland height, volume, and shape in relation to long-term endocrine abnormalities in pediatric brain tumor survivors.
Retrospective cohort study.
A total of 56 pediatric brain tumor survivors (50% male) with an average follow-up of 10.8 ± 1.6 years; 44.6% underwent radiotherapy, and 48% were treated with chemotherapy. One-third of the cohort experienced at least one pituitary hormone deficiency.
FIELD STRENGTH/SEQUENCE: 3 T, including volumetric 1 mm sagittal post-contrast T1 images.
Pituitary height, volume, and shape (concave, horizontal, convex) were measured. Endocrine abnormalities were diagnosed through routine serum hormone testing.
The t test, chi-square test, and Pearson test with significance at P < 0.05 were used. Receiver-operating characteristic (ROC) analysis assessed the association of imaging parameters and pituitary dysfunction.
Radiation and chemotherapy treatment were significantly associated with pituitary hormone deficiencies. There were significant differences in pituitary height and volume in patients with pituitary hormone deficiencies compared with normal pituitary function (4.0 ± 1.3 vs. 5.5 ± 1.5 mm, and 354.2 ± 198.0 vs. 568.3 ± 184.4 mm, respectively). There was a significant association between radiation therapy and pituitary gland shape, with 60.0% of patients who received radiation therapy exhibiting a pituitary shape categorized as concave, 32.0% as horizontal, and 8.0% as convex, compared to 9.7%, 74.2%, and 16.1%, respectively. ROC analysis for association with pituitary hormone deficiency was 0.81, 0.8, and 0.74 for pituitary height, volume, and shape, respectively.
Cranial irradiation and chemotherapy in pediatric brain tumors are associated with endocrine dysfunction, with decreased pituitary height, volume, and concave shape in long-term MRI surveillance are associated with such late endocrine dysfunction.
4 TECHNICAL EFFICACY: Stage 2.
儿童脑癌幸存者常因颅脑照射和化疗而出现下丘脑 - 垂体功能障碍。虽然激素缺乏已得到研究,但长期MRI检查中垂体大小和形状的变化及其与内分泌功能障碍的关系仍未得到充分探索。
评估儿童脑肿瘤幸存者垂体高度、体积和形状与长期内分泌异常的关系。
回顾性队列研究。
共56名儿童脑肿瘤幸存者(50%为男性),平均随访10.8±1.6年;44.6%接受过放射治疗,48%接受过化疗。三分之一的队列经历过至少一种垂体激素缺乏。
场强/序列:3T,包括容积为1mm的矢状位增强后T1图像。
测量垂体高度、体积和形状(凹陷、水平、凸起)。通过常规血清激素检测诊断内分泌异常。
采用t检验、卡方检验和Pearson检验,显著性水平为P<0.05。受试者操作特征(ROC)分析评估成像参数与垂体功能障碍的关联。
放射治疗和化疗与垂体激素缺乏显著相关。垂体激素缺乏患者的垂体高度和体积与垂体功能正常患者相比有显著差异(分别为4.0±1.3 vs. 5.5±1.5mm,以及354.2±198.0 vs. 568.3±184.4mm)。放射治疗与垂体形状之间存在显著关联,接受放射治疗的患者中,60.0%的垂体形状分类为凹陷,32.0%为水平,8.0%为凸起,而未接受放射治疗的患者分别为9.7%、74.2%和16.1%。垂体高度、体积和形状与垂体激素缺乏关联的ROC分析分别为0.81、0.8和0.74。
儿童脑肿瘤的颅脑照射和化疗与内分泌功能障碍相关,长期MRI监测中垂体高度降低、体积减小和形状凹陷与这种晚期内分泌功能障碍相关。
4 技术效能:2级